menu
    • menu

    Company profile for Can-Fite BioPharma

    NEW Drugs in Dev: 4
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and liver diseases. The company's lead drug candidate is CF101 (Piclidenoson), which is in Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis. It also develops CF102 (Namodenoson) that is in Phase II clinical trials for the tr...
    Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and liver diseases. The company's lead drug candidate is CF101 (Piclidenoson), which is in Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis. It also develops CF102 (Namodenoson) that is in Phase II clinical trials for the treatment of liver cancer and non-alcoholic fatty liver diseases, as well as for hepatocellular carcinoma and hepatitis C virus diseases; and CF602, which is in pre-clinical trial for the treatment of sexual dysfunction.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Can-Fite BioPharmaIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    10 Bareket Street, Kiryat Matalon, PO Box 7537, Petah-Tikva, 4951778
    Telephone
    Telephone
    972 3 924 1114
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.canfite.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/canfitepharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Can-Fite Reports 2025 Financial Results, Phase 2a Cancer Data
    Can-Fite Reports 2025 Financial Results, Phase 2a Cancer Data

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263128/0/en/Can-Fite-Reports-2025-Financial-Results-and-Ongoing-Clinical-Progress-Highlighting-Positive-Data-in-Phase-2a-Pancreatic-cancer-and-9-Years-Cancer-Free-Survival-in-Liver-Cancer-Pati.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Can-Fite Secures Israeli Patent for Namodenoson Anti-Obesity Use
    Can-Fite Secures Israeli Patent for Namodenoson Anti-Obesity Use

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257054/0/en/Can-Fite-Expands-Namodenoson-anti-Obesity-Franchise-with-Israeli-Patent-Allowance.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Can-Fite Exercises Warrants, Generating $4.0M In Gross Proceeds
    Can-Fite Exercises Warrants, Generating $4.0M In Gross Proceeds

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249502/0/en/Can-Fite-Announces-Exercise-of-Warrants-for-Approximately-4-0-Million-in-Gross-Proceeds.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Can-Fite's Namodenoson Succeeds in Ph 2A Pancreatic Cancer Study
    Can-Fite's Namodenoson Succeeds in Ph 2A Pancreatic Cancer Study

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249198/0/en/Can-Fite-s-Namodenoson-Successfully-Meets-Primary-Endpoint-in-Phase-2a-Pancreatic-Cancer-Study.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Can-Fite Granted Canadian Patent For Namodenoson As Anti-Obesity
    Can-Fite Granted Canadian Patent For Namodenoson As Anti-Obesity

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234404/0/en/Can-Fite-Receives-Canadian-Patent-Allowance-for-Namodenoson-as-an-Anti-Obesity-Therapy.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Cirrhosis Patient Get Liver Transplant After Namodenoson
    Cirrhosis Patient Get Liver Transplant After Namodenoson

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3232840/0/en/Can-Fite-Patient-with-Decompensated-Liver-Cirrhosis-Successfully-Undergoes-Liver-Transplantation-Following-Treatment-with-Namodenoson.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search